T. Rowe Price Associates
BMR

T. Rowe Price Associates’s BIOMED REALTY TRUST INC BMR Stock Holding History

T. Rowe Price Associates’s Portfolio BMR Stock Details BMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-51,934
Closed -$1.23M – 2579
2015
Q4 		$1.23M Buy
51,934
+3,534
+7% +$82.2K ﹤0.01% 1634
2015
Q3 		$967K Hold
48,400
– – ﹤0.01% 1720
2015
Q2 		$936K Hold
48,400
– – ﹤0.01% 1771
2015
Q1 		$1.1M Hold
48,400
– – ﹤0.01% 1704
2014
Q4 		$1.04M Hold
48,400
– – ﹤0.01% 1710
2014
Q3 		$978K Hold
48,400
– – ﹤0.01% 1739
2014
Q2 		$1.06M Hold
48,400
– – ﹤0.01% 1719
2014
Q1 		$992K Hold
48,400
– – ﹤0.01% 1696
2013
Q4 		$877K Hold
48,400
– – ﹤0.01% 1711
2013
Q3 		$900K Buy
48,400
+7,700
+19% +$151K ﹤0.01% 1698
2013
Q2 		$823K Buy
+40,700
New +$881K ﹤0.01% 1712

Other funds holding BMR

UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return
MAM
Mizuho Asset Management Tokyo, Japan $462M AUM 15.39% 1-Year Est. Return
KB
Kimelman & Baird New York $1.36B AUM 26.27% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates's BMR Position: Q1 2016 in Review

T. Rowe Price Associates sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 51,934 shares — an estimated $1.23M sold.

T. Rowe Price Associates first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $1.23M in Q4 2015. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • T. Rowe Price Associates reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • T. Rowe Price Associates sold 51,934 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $1.23M.
  • T. Rowe Price Associates first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • T. Rowe Price Associates's BIOMED REALTY TRUST INC position peaked at $1.23M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.